Sanofi | SNY - Trade Debtors


Sanofi reported EUR482M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
AbbVie USD 12.48B 110M Mar/2026
Amgen USD 10.23B 1.09B Jun/2026
AstraZeneca USD 18.86B 972M Jun/2026
Bristol-Myers Squibb USD 13.83B 535M Jun/2026
Canopy Growth CAD 36.29M 104.13M Mar/2026
Corcept Therapeutics USD 76.92M 37.85M Jun/2026
Drreddys Laboratories INR 123.17B 121.76B Mar/2026
Eli Lilly USD 21.18B 1.02B Mar/2026
Genmab DKK 1.17B 119M Dec/2025
GlaxoSmithKline GBP 8.07B 137M Jun/2026
Glaxosmithkline GBP 10.49B 40.6M Mar/2026
J&J USD 22.54B 1.21B Mar/2026
Lakefront Biotherapeutics EUR 54.03M 145.72M Mar/2026
Merck USD 12.21B 435M Mar/2026
Novartis USD 9.85B 252M Jun/2026
Novartis USD 9.6B 2.69B Mar/2026
Pacira USD 132.42M 6.78M Jun/2026
Perrigo USD 697.1M 84.3M Mar/2026
Pfizer USD 16.19B 19M Jun/2026
Phibro Animal Health USD 215.87M 2.02M Dec/2025
Prestige Brands USD 191.92M 1.46M Mar/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sanofi EUR 492M 10M Jun/2026
Sanofi EUR 482M 85M Mar/2026
Supernus Pharmaceuticals USD 211.66M 29.47M Jun/2026
UCB EUR 1.97B 54M Dec/2025
Zoetis USD 1.51B 84M Mar/2026